Heart transplantations at the Heart Center IKEM, Prague, Czech Republic.

J. Pirk, I. Malek, I. Netuka, L. Hoskova, E. Pokorna, T. Kotulak, M. Urban

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The heart transplant program at the Institute for Clinical and Experimental Medicine in Prague was established on January 31, 1984. Through November 2012, 881 orthotopic cardiac transplantations have been performed, with an annual rate of about 40 procedures. Current legislation concerning solid organ transplantations in the Czech Republic is described. Like other centers, we have noticed an increasing age of donors, and, reflecting the shortage of grafts, we have expanded our selection criteria for heart transplantation. The advent of a mechanical circulatory support program at our center in April 2003 has given us another valuable tool in the management of chronic heart failure patients. Currently, around half of our patients are transplanted from mechanical support. Nonischemic etiology of heart failure is a leading cause of transplantation at our center, followed by ischemic cardiomyopathy, valvular heart lesions, and adult congenital heart diseases. Our current immunosupression protocol, including induction therapy, is outlined in detail and survival rates, as well as most common complications and our treatment strategies, are also discussed.

Original languageEnglish (US)
Pages (from-to)135-143
Number of pages9
JournalUnknown Journal
StatePublished - 2012

Fingerprint

Czech Republic
Heart Transplantation
Heart Failure
Transplants
Clinical Medicine
Organ Transplantation
Cardiomyopathies
Legislation
Patient Selection
Biomedical Research
Heart Diseases
Survival Rate
Transplantation
Tissue Donors
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pirk, J., Malek, I., Netuka, I., Hoskova, L., Pokorna, E., Kotulak, T., & Urban, M. (2012). Heart transplantations at the Heart Center IKEM, Prague, Czech Republic. Unknown Journal, 135-143.

Heart transplantations at the Heart Center IKEM, Prague, Czech Republic. / Pirk, J.; Malek, I.; Netuka, I.; Hoskova, L.; Pokorna, E.; Kotulak, T.; Urban, M.

In: Unknown Journal, 2012, p. 135-143.

Research output: Contribution to journalArticle

Pirk, J, Malek, I, Netuka, I, Hoskova, L, Pokorna, E, Kotulak, T & Urban, M 2012, 'Heart transplantations at the Heart Center IKEM, Prague, Czech Republic.', Unknown Journal, pp. 135-143.
Pirk J, Malek I, Netuka I, Hoskova L, Pokorna E, Kotulak T et al. Heart transplantations at the Heart Center IKEM, Prague, Czech Republic. Unknown Journal. 2012;135-143.
Pirk, J. ; Malek, I. ; Netuka, I. ; Hoskova, L. ; Pokorna, E. ; Kotulak, T. ; Urban, M. / Heart transplantations at the Heart Center IKEM, Prague, Czech Republic. In: Unknown Journal. 2012 ; pp. 135-143.
@article{91b1dc9986b74740b1dc37d89886eee8,
title = "Heart transplantations at the Heart Center IKEM, Prague, Czech Republic.",
abstract = "The heart transplant program at the Institute for Clinical and Experimental Medicine in Prague was established on January 31, 1984. Through November 2012, 881 orthotopic cardiac transplantations have been performed, with an annual rate of about 40 procedures. Current legislation concerning solid organ transplantations in the Czech Republic is described. Like other centers, we have noticed an increasing age of donors, and, reflecting the shortage of grafts, we have expanded our selection criteria for heart transplantation. The advent of a mechanical circulatory support program at our center in April 2003 has given us another valuable tool in the management of chronic heart failure patients. Currently, around half of our patients are transplanted from mechanical support. Nonischemic etiology of heart failure is a leading cause of transplantation at our center, followed by ischemic cardiomyopathy, valvular heart lesions, and adult congenital heart diseases. Our current immunosupression protocol, including induction therapy, is outlined in detail and survival rates, as well as most common complications and our treatment strategies, are also discussed.",
author = "J. Pirk and I. Malek and I. Netuka and L. Hoskova and E. Pokorna and T. Kotulak and M. Urban",
year = "2012",
language = "English (US)",
pages = "135--143",
journal = "ImmunoMethods",
issn = "1046-2023",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Heart transplantations at the Heart Center IKEM, Prague, Czech Republic.

AU - Pirk, J.

AU - Malek, I.

AU - Netuka, I.

AU - Hoskova, L.

AU - Pokorna, E.

AU - Kotulak, T.

AU - Urban, M.

PY - 2012

Y1 - 2012

N2 - The heart transplant program at the Institute for Clinical and Experimental Medicine in Prague was established on January 31, 1984. Through November 2012, 881 orthotopic cardiac transplantations have been performed, with an annual rate of about 40 procedures. Current legislation concerning solid organ transplantations in the Czech Republic is described. Like other centers, we have noticed an increasing age of donors, and, reflecting the shortage of grafts, we have expanded our selection criteria for heart transplantation. The advent of a mechanical circulatory support program at our center in April 2003 has given us another valuable tool in the management of chronic heart failure patients. Currently, around half of our patients are transplanted from mechanical support. Nonischemic etiology of heart failure is a leading cause of transplantation at our center, followed by ischemic cardiomyopathy, valvular heart lesions, and adult congenital heart diseases. Our current immunosupression protocol, including induction therapy, is outlined in detail and survival rates, as well as most common complications and our treatment strategies, are also discussed.

AB - The heart transplant program at the Institute for Clinical and Experimental Medicine in Prague was established on January 31, 1984. Through November 2012, 881 orthotopic cardiac transplantations have been performed, with an annual rate of about 40 procedures. Current legislation concerning solid organ transplantations in the Czech Republic is described. Like other centers, we have noticed an increasing age of donors, and, reflecting the shortage of grafts, we have expanded our selection criteria for heart transplantation. The advent of a mechanical circulatory support program at our center in April 2003 has given us another valuable tool in the management of chronic heart failure patients. Currently, around half of our patients are transplanted from mechanical support. Nonischemic etiology of heart failure is a leading cause of transplantation at our center, followed by ischemic cardiomyopathy, valvular heart lesions, and adult congenital heart diseases. Our current immunosupression protocol, including induction therapy, is outlined in detail and survival rates, as well as most common complications and our treatment strategies, are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=84879150230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879150230&partnerID=8YFLogxK

M3 - Article

C2 - 23721016

AN - SCOPUS:84879150230

SP - 135

EP - 143

JO - ImmunoMethods

JF - ImmunoMethods

SN - 1046-2023

ER -